DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)
Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.
DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)
Industry:
Biotechnology Medical Non Profit
Founded:
2003-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.dndi.org
Total Employee:
101+
Status:
Active
Contact:
+41 22 906 9230
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Investors List
la Caixa
la Caixa investment in Grant - Drugs for Neglected Diseases initiative (DNDi)
Official Site Inspections
http://www.dndi.org Semrush global rank: 1.63 M Semrush visits lastest month: 15.37 K
- Host name: od-b2b5f0.ch2.infomaniak.ch
- IP address: 84.16.78.12
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Drugs for Neglected Diseases initiative (DNDi)"
About DNDi - Drugs for Neglected Diseases initiative (DNDi)
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients …See details»
Who we are | DNDi
In 2003, the Indian Council of Medical Research (ICMR), the Oswaldo Cruz Foundation in Brazil, the Kenyan Medical Research Institute (KEMRI), the Malaysian Ministry of Health, and the …See details»
DNDi North America
DNDi puts patients – not profits – at the heart of R&D. ... In 2003, DNDi was founded by MSF, the World Health Organization, Institut Pasteur, the Indian Council of Medical Research, the Oswaldo Cruz Foundation in Brazil, the …See details»
Drugs for Neglected Diseases Initiative - Wikipedia
The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness (human African trypanosomiasis, HAT), Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. DNDi's malaria activities were transferred to Medicines for Malaria VentureSee details»
About | DNDi North America - dndina.org
DNDi has built a team of more than 240 employees working across nine offices. DNDi North America, created in 2008 and based in New York City, is a registered 501(c)(3) non-profit that works to strengthen and expand scientific networks, …See details»
Drugs for Neglected Diseases initiative - DNDi | LinkedIn
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients ...See details»
DNDi
DNDi was founded in 2003 by Doctors Without Borders/Médecins Sans Frontières (MSF), the Institut Pasteur, the Kenya Medical Research Institute, the Oswaldo Cruz Foundation in Brazil, the Indian Council of Medical Research, …See details»
Our research | DNDi North America - dndina.org
DNDi invests in bringing all-new treatments through the research and development (R&D) pipeline – both by repurposing or modifying drugs from other therapeutic areas and by identifying and developing entirely new chemical …See details»
Drugs for Neglected Diseases initiative - DNDi | LinkedIn
Drugs for Neglected Diseases initiative - DNDi | 43,724 followers on LinkedIn. International non-profit developing safe, effective, and affordable treatments for the most neglected patients. | …See details»
Our story: 20 years of DNDi
Browse through the timeline of DNDi's first 20 years. ... Malaysia (Ministry of Health), and France (Institut Pasteur) come together to create DNDi as a non-profit organization that develops treatments for neglected diseases. DNDi …See details»
Drugs for Neglected Diseases Initiative - DNDi
"The Drugs for Neglected Diseases initiative (DNDi) is a not-for-profit research and development organization that discovers, develops, and delivers safe, effective, and affordable treatments …See details»
Five ways innovation is changing the fight against Neglected …
Mr Assani also knows the power of innovation. For over an hour he spoke with DNDi’s clinical team, insisting that science is needed for people at risk of river blindness.. Mr Assani’s appeal …See details»
Drugs for Neglected Diseases initiative model of drug ... - PubMed
The Drugs for Neglected Diseases initiative (DNDi) is a patients' needs-driven organization committed to the development of new treatments for neglected diseases. Created in 2003, …See details»
How we work | DNDi
DNDi acts as a conductor of a ‘virtual orchestra’ of over 200 partners around the world to develop treatments for patients – not profits. ... while delivering on our objectives in diseases that we …See details»
Drugs for Neglected Diseases Initiative DNDi - Charity Navigator
Click here to search for this organization's Forms 990 on the IRS website (if any are available). Simply enter the organization's name (Drugs for Neglected Diseases Initiative DNDi ) or EIN …See details»
Drugs for Neglected Diseases initiative - DNDi | LinkedIn
Drugs for Neglected Diseases initiative - DNDi | 32,281 followers on LinkedIn. International non-profit developing safe, effective, and affordable treatments for the most neglected patients. | …See details»
Drugs for Neglected Diseases initiative (DNDi)
Drugs for Neglected Diseases initiative (DNDi). 21,467 likes · 12 talking about this. Non-profit developing safe, effective & affordable treatments for the most neglected patients.See details»
Strategy | DNDi
Powering our ambitions. We will maintain a diverse workforce and an inclusive culture, which are central to the success of DNDi’s mission and programmes.; We will adopt best practices in …See details»
Molecular basis of the phosphorothioation-sensing antiphage …
2 days ago The S. enterica dndI gene was amplified and inserted into the pET28a vector. The generated plasmid was subsequently introduced into E. coli ... (HNH) nuclease domain, similar …See details»
Our leadership | DNDi
DNDi’s diverse global team of over 240 employees and close consultants represent more than 30 nationalities and bring essential skills and experience from the academic, non-profit, private, …See details»